Health Research Policy and Systems (Mar 2022)

Rapid method through routine data to evaluate real-world vaccine effectiveness against coronavirus disease 2019 (COVID-19) infection: lessons from Thailand

  • Natthaprang Nittayasoot,
  • Panithee Thammawijaya,
  • Piyanit Tharmaphornpilas,
  • Chalo Sansilapin,
  • Chuleeporn Jiraphongsa,
  • Rapeepong Suphanchaimat

DOI
https://doi.org/10.1186/s12961-022-00821-6
Journal volume & issue
Vol. 20, no. 1
pp. 1 – 5

Abstract

Read online

Abstract The objective of this article is to draw lessons from the Thai experience in estimating vaccine effectiveness (VE) for coronavirus disease 2019 (COVID-19) based on routine service data. We found that a matched case–control design, using probability-based controls representing the varying vaccine coverage across the population over time, yielded a valid result for VE assessment. The proposed design has an advantage in its applicability drawing from the routine data monitoring system. Future studies that exercise other designs, such as test-negative and cohort studies, are recommended in order to compare and contrast the findings across different designs. To implement a continuous monitoring system on VE, the integration of data from different sources is needed. This requires long-term investment in the data monitoring system for the entire healthcare system.

Keywords